Concept, PoC, for its precision cancer vaccine concept targeting non-conventional ERV tumor antigens shared across patients. New data confirming the preclinical PoC is presented at the ESMO ...
Tissue Penetration: Consistent with the recently updated trial protocol, tissue Css levels were evaluated in addition to plasma Css levels. The 80 mg/day dose, in both treatment arms, achieved tissue ...
Cancer immunotherapy is a therapy used to treat ... Here the authors report the design and characterization of thermal-responsive bacteria engineered to release interleukin-15 & interleukin ...